Release Date: 21/10/09 09:02 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 775.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%